Healthcare Providers and Services
Company Overview of Theranos, Inc.
Theranos, Inc. operates clinical laboratories in Arizona, California, and Pennsylvania. The company specializes in the areas of oncology, pediatrics, and geriatrics. It also designs, develops, and manufactures testing products in the United States. Theranos, Inc. was founded in 2003 and is based in Palo Alto, California.
1701 Page Mill Road
Palo Alto, CA 94304
Founded in 2003
Key Executives for Theranos, Inc.
Founder, Chairman, Co-Chairman of Scientific & Medical Advisory Board and Chief Executive Officer
Senior Vice President of Operations
Senior Vice President of Corporate Communications & Investor Relations
Vice President of Regulatory & Quality
Compensation as of Fiscal Year 2016.
Theranos, Inc. Key Developments
Theranos, Inc. Announces Board Appointments
Jan 17 17
Theranos, Inc. announced that engineering and biomedical device design experts have joined the company’s newly created Technology Advisory Board (TAB), a counterpart to the
Science and Medical Advisory Board formed last year. Dr. Channing Robertson and Howie Rosen will co-lead the board of academics, executives and entrepreneurs. Four of them are members of the National Academy of Engineering, a part of the National Academy of Sciences. The eight-member TAB has had full access to Theranos proprietary technologies, associated data and team members. The board will work alongside Theranos leadership and internal research and development teams in various areas, including advising the company on peer-reviewed publication submissions and on presentations at scientific meetings.
Theranos Inc. to Lay Off 41% of Staff
Jan 10 17
Theranos Inc. announced plans to lay off 41% of its staff. The company announced that it will eliminate 155 positions, leaving 220 employees to work on a new tabletop blood-testing device called the miniLab. In October, 2016 it fired 340 workers and announced it would close its clinical labs and consumer outlets in Arizona, California and Pennsylvania.
Theranos, Inc. Announces Executive Appointments
Dec 12 16
Theranos, Inc. has announced that key roles have been filled in the company’s executive ranks, with the naming of John McChesney to senior vice president of operations and Tali Mackay to senior vice president of corporate communications and investor relations, as well as the promotion of David Taylor to the role of general counsel. Dr. Gregory J. Tsongalis was appointed to the company’s Scientific and Medical Advisory Board (SMAB). John McChesney joins the company with medical device manufacturing expertise, having served in roles of increasing responsibility at GenapSys, Inc.; Thermo Fisher Scientific; and Medtronic. He has extensive experience leading teams through periods of change, including acquisitions, quality system deployments, high growth, development of manufacturing centers of excellence, and building global supply chains. Tali Mackay brings high-stakes communications expertise, including crisis communications and issues management, corporate branding and reputation, and mergers and acquisitions. Her experience encompasses roles at Genentech, Baxter, and global public relations firms. David Taylor joined Theranos as senior litigation counsel in May and thereafter served as acting general counsel. Taylor previously practiced with Munger, Tolles & Olson LLP and Williams & Connolly LLP and has over 10 years of experience in complex litigation. Dr. Gregory J. Tsongalis has held several clinical and academic positions and has been a member of numerous corporate scientific advisory boards. He received his Ph.D. in pathology from the University of Medicine and Dentistry of New Jersey (now Rutgers University) and completed his postdoctoral training in molecular oncology and clinical chemistry/molecular pathology at the University of North Carolina at Chapel Hill. His area of expertise is in clinical molecular diagnostic applications and technology development, and he conducts research in the pathogenesis of human cancers, personalized medicine, and disruptive technologies. He has served on numerous committees of the AACC, ASIP, FASEB, and AMP, where he is a past president.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|